bpc 157 auto injector BPC-157 Benefits, Dosage & Before/After Results BPC-157 Injection vs Oral Peptide:

Subcutaneous injection near the injury site delivers high local concentrations while still providing systemic distribution through circulation

The protocol is typically administered as subcutaneous injections over a 4-week or 8-week cycle

Potential drug interactions Lack of comprehensive study of the peptides on PCACs list means that the potential for and severity of drug interactions are not well understood

Has no significant side effects , but should be used at the correct dosage .

Both the NAc and VTA are key components of mesolimbic circuits responsible for encoding the salience and motivational valence of pain